Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Cell Signaling Technology Renovates Danvers Inn for New Headquarters
Cell Signaling Technology, based in Beverly, Mass., will renovate the 125-room Kings Grant Inn in Danvers, Mass., as its new headquarters facility. Cell Signaling is a biotechnology company that develops antibodies for cancer research.
United Therapeutics Constructs Ovarian Cancer Research Lab
United Therapeutics will construct a 40,000-sf ovarian cancer research lab and pharmaceutical manufacturing building adjacent to its headquarters in Silver Spring, Md. The $15-million lab is part of a 190,000-sf biotechnology campus planned by United Therapeutics. The new facility will manufacture OvaRex, an alternative to chemotherapy, in bulk for shipping to third-party manufacturers that will form it into pills.
Lahey Clinic Plans Burlington Expansion
The Lahey Clinic is planning a $135 million expansion of its Burlington, Mass. hospital. The project will add over seven stories, over 70 beds, a cancer center, four operation rooms, and a four-level parking garage with 1,200 spaces. The Lahey Clinic currently has 259 licensed beds.
Georgia Tech Plans Nanotechnology Center
The Georgia Institute of Technology will construct the Nanotechnology Research Center on its Atlanta campus as early as next year, with official occupancy to follow in three years. Funded by a $36-million pledge from an anonymous donor, the facility will be sited where the university’s old nuclear reactor building now stands.
Neurocrine Biosciences Builds San Diego Facility
Neurocrine Biosciences is developing the first phase of a 13.4-acre project in San Diego's Carmel Valley. Designed by Dowler Grumman Architects, the 200,000-sf, two-building project is being constructed by Ledcor Petty Construction.